惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

N
News | PayPal Newsroom
IT之家
IT之家
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
大猫的无限游戏
大猫的无限游戏
GbyAI
GbyAI
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
L
LangChain Blog
S
SegmentFault 最新的问题
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
Project Zero
Project Zero
P
Privacy & Cybersecurity Law Blog
V
Vulnerabilities – Threatpost
博客园 - 三生石上(FineUI控件)
Recorded Future
Recorded Future
The Hacker News
The Hacker News
C
CXSECURITY Database RSS Feed - CXSecurity.com
C
CERT Recently Published Vulnerability Notes
宝玉的分享
宝玉的分享
aimingoo的专栏
aimingoo的专栏
T
Tor Project blog
T
The Exploit Database - CXSecurity.com
Schneier on Security
Schneier on Security
H
Help Net Security
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
M
MIT News - Artificial intelligence
W
WeLiveSecurity
P
Proofpoint News Feed
A
About on SuperTechFans
S
Securelist
I
InfoQ
G
Google Developers Blog
博客园 - 司徒正美
博客园 - 叶小钗
Latest news
Latest news
F
Fortinet All Blogs
G
GRAHAM CLULEY
腾讯CDC
Jina AI
Jina AI
S
Schneier on Security
I
Intezer
V
Visual Studio Blog
美团技术团队
V2EX - 技术
V2EX - 技术
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
The Cloudflare Blog
Microsoft Security Blog
Microsoft Security Blog
Blog — PlanetScale
Blog — PlanetScale
P
Proofpoint News Feed
罗磊的独立博客
Y
Y Combinator Blog

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Tech-Ignored: How AI Innovation Is Widening The Digital Health Divide
Lisa Fitzpat · 2026-05-16 · via Forbes - Healthcare
Asian Chinese senior woman using smart phone reading text message in living room of her apartment in city

Asian Chinese senior woman using smart phone reading text message in living room of her apartment in city

getty

Earlier this year, OpenAI released ChatGPT Health, offering digitally-savvy consumers a tool to aggregate health data scattered across disparate sites and portals. Chronic disease burden and costs in the US is most often disproportionately centered in underserved communities where people are less likely to use or benefit from this innovation. Health technology isn’t designed and marketed with these communities in mind, so, who is this for?

In a recent post, Sergei Polevikov, tech expert and founder of AI Health Uncut, describes uploading his health records to the new OpenAI health platform and offers a cautionary tale. The analysis hallucinated parts of his health history and he encountered administrative hurdles in the process. Polevikov says, “Automation helps me with efficiency and saves me time, but I don’t need AI to explain what is happening to me healthwise. The distribution of [these tools] is one-sided and people like me need them least.”

If someone like Polevikov encounters navigation roadblocks with AI-driven tools, what does this signal for those with low digital literacy and whose health and tech concerns are not included in the design and marketing of these tools?

Tech-Ignored, Not Tech-Averse

My recent street interviews about AI in Mobile, Alabama offer context for the disconnect between the surge in AI tools and tech support needs for those with low digital literacy. Leevonis Fisher, a community leader and founder of the Bay Area Women Coalition, highlighted how far we have left people behind. When I asked what she thought about AI, she said, "I think it’s all fake." I pivoted to ask about her smartphone use. Fisher has an iPhone and uses Siri, Alexa and voice-to-text almost daily. Despite how entrenched these tools are in her routine, she had no idea they are AI-driven. To her, AI was a buzzword for an untrustworthy computer robot that creates fake videos for social media.

This is concerning. While engineers and tech gurus continue to create tools for ease and efficiency for those who need them least, those who could benefit most are omitted from design conversations and like Fisher, often don’t even know they already use AI-driven solutions every day. These communities are also least likely to own wearables, purchase direct-to-consumer diagnostics or log in to their electronic health records consistently. Unless we close these information and access gaps, ongoing AI and tech innovation will widen them. Furthermore, innovation that misses underserved, high disease burden communities is a missed market opportunity. The full economic potential of AI in healthcare won’t be achieved if the tools are only utilized by the healthiest and most tech-literate.

MORE FOR YOU

Are we ok with that?

Fisher likely represents millions of people across the country we might label tech-averse. But given her daily use of tech, she isn’t. She is tech-ignored. She doesn’t trust AI because no one has invited her to understand its utility or function in her life beyond Siri and Alexa. If we don’t understand her habits, constraints and specific needs, the most advanced AI in the world will only serve to widen the knowledge and use gaps.

Shaping AI By And For People

We are not powerless to address this. Organizations and efforts are emerging to shape AI policy and access. Last fall, the MacArthur Foundation, Omidyar Network, and eight other major philanthropies launched Humanity AI, a five-year, $500 million initiative to ensure that AI is shaped by and for people. According to Michele Jawando, president of Omidyar Network, "Tech has incredible potential but must be steered by humans, not the other way around. The future will not be written by algorithms, it will be written by people as a collective force."

We should grapple with these questions and work toward consensus to build tech for everybody, but not before raising awareness and seeking context, experience and insight from the people we keep leaving behind.